33 studies found for:    " August 13, 2008":" September 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 13, 2008":" September 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 10 mg oral solution;   Drug: GSK1265744 5 mg tablet
2 Completed TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
Conditions: HIV;   AIDS;   Fungal Infection
Intervention: Drug: TMC125
3 Completed IMARA, Adapting SiHLE for Detained African American Adolescent Females
Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
4 Completed Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)
Condition: HIV Infections
Intervention: Biological: Tat protein
5 Completed An Affect Management Intervention for Juvenile Offenders
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
6 Completed Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru
Condition: HIV Infections
Interventions: Device: HIV-testing motivational videos;   Device: Standard public health text
7 Completed Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
Conditions: HIV Infections;   Fatigue
Intervention: Drug: Armodafinil
8 Completed
Has Results
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Condition: HIV Infections
Intervention: Drug: raltegravir
9 Completed Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir and raltegravir
10 Completed
Has Results
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
Condition: HIV Infections
Intervention: Drug: Raltegravir
11 Unknown  Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
12 Completed Affect Management Intervention for Early Adolescents Wtih Mental Health Problems
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
13 Completed Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Condition: HIV Infections
Intervention:
14 Completed Attitudes and Beliefs and the Steps of HIV Care
Condition: Human Immunodeficiency Virus Infections
Intervention: Behavioral: Questionnaire
15 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
16 Active, not recruiting Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine
Condition: HIV-1 Infection
Intervention: Drug: Emtricitabine
17 Unknown  Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
Intervention: Drug: Raltegravir and Atazanavir
18 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
19 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
20 Completed Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Conditions: Cholera;   Vibrio Infections;   Diarrhea
Interventions: Biological: CholeraGarde®;   Biological: Placebo

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years